DANBURY, Conn., May 7, 2012 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) will issue its second quarter fiscal year 2012 financial results on May 10, 2012. Following the release of the company’s financial results, Biodel’s senior management will host a conference call to discuss the results and provide an update on the company’s progress.
May 10, 2012 schedule: | |||
6:00 am EDT: | Q2 fiscal year 2012 results will be distributed | ||
8:15 am EDT: | Conference call participants should dial: | ||
+1 ( 877 ) 303 - 8028 (United States) or | |||
+1 ( 760 ) 536 - 5167 (International) | |||
8:30 am EDT: | Conference call begins | ||
Interested parties may access a live audio webcast of the conference call in the investor section of Biodel’s website at www.biodel.com. The audio webcast will be archived and available for replay through the website.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company’s website at www.biodel.com.
BIOD-G
Contact: Seth D. Lewis, +1-646-378-2952
SOURCE Biodel Inc.
